IRIS
FERRAROTTI, ILARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.028
AS - Asia 1.669
EU - Europa 1.336
SA - Sud America 270
AF - Africa 41
Totale 5.344
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.969
CN - Cina 815
SG - Singapore 425
IE - Irlanda 258
HK - Hong Kong 254
RU - Federazione Russa 229
BR - Brasile 223
DE - Germania 183
IT - Italia 159
FI - Finlandia 117
GB - Regno Unito 99
UA - Ucraina 99
VN - Vietnam 77
SE - Svezia 57
CA - Canada 41
FR - Francia 24
ZA - Sudafrica 23
IN - India 21
BE - Belgio 19
AR - Argentina 16
AT - Austria 16
PL - Polonia 15
NL - Olanda 14
MX - Messico 12
CZ - Repubblica Ceca 11
IQ - Iraq 11
ES - Italia 10
EC - Ecuador 9
JP - Giappone 8
BD - Bangladesh 7
LT - Lituania 7
CH - Svizzera 6
CL - Cile 6
PY - Paraguay 6
TR - Turchia 6
DK - Danimarca 4
JO - Giordania 4
LB - Libano 4
MA - Marocco 4
PK - Pakistan 4
SK - Slovacchia (Repubblica Slovacca) 4
TN - Tunisia 4
UZ - Uzbekistan 4
CO - Colombia 3
ID - Indonesia 3
IL - Israele 3
MU - Mauritius 3
PE - Perù 3
QA - Qatar 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BB - Barbados 2
BY - Bielorussia 2
HU - Ungheria 2
IR - Iran 2
KE - Kenya 2
KR - Corea 2
NP - Nepal 2
VE - Venezuela 2
CY - Cipro 1
DZ - Algeria 1
ET - Etiopia 1
GH - Ghana 1
GP - Guadalupe 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MM - Myanmar 1
NG - Nigeria 1
PH - Filippine 1
PR - Porto Rico 1
SA - Arabia Saudita 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UY - Uruguay 1
Totale 5.344
Salva come PNG Salva come JPEG
Città #
Dublin 258
Hong Kong 250
Chandler 244
Dallas 210
Beijing 201
Ashburn 192
Singapore 182
Nanjing 151
Jacksonville 100
Boardman 85
Ann Arbor 78
Los Angeles 64
Redondo Beach 63
Munich 60
Helsinki 57
New York 53
Lawrence 45
Princeton 45
Medford 44
Moscow 42
Nanchang 42
Dearborn 40
Shanghai 35
Wilmington 34
Ho Chi Minh City 33
Shenyang 32
Changsha 30
São Paulo 28
Houston 27
Buffalo 26
Turku 24
Jiaxing 23
Hebei 22
Brussels 19
Toronto 19
Hanoi 18
Pavia 18
San Jose 18
Tianjin 18
Vinnytsia 17
The Dalles 16
Brooklyn 15
Falkenstein 15
Milan 15
Montesilvano Marina 15
Nuremberg 15
Chongqing 14
Hangzhou 14
Johannesburg 14
Piemonte 14
Rome 14
Woodbridge 14
Phoenix 13
Warsaw 13
Chicago 12
London 12
Amsterdam 11
Frankfurt am Main 11
Kunming 11
Stockholm 11
Council Bluffs 10
Redwood City 10
Washington 10
Denver 9
Montreal 9
Guangzhou 8
Norwalk 8
Orem 8
Poplar 8
Tokyo 8
Vienna 8
Atlanta 7
Jinan 7
Santa Clara 7
Turin 7
Des Moines 6
Fairfield 6
Hefei 6
Seattle 6
Zhengzhou 6
Charlotte 5
Düsseldorf 5
Hyderabad 5
Rio de Janeiro 5
San Francisco 5
Amman 4
Asunción 4
Baghdad 4
Brasília 4
Brno 4
Bắc Ninh 4
Canyon Country 4
Chennai 4
Columbus 4
Hårlev 4
La Prairie 4
Nova Iguaçu 4
Olomouc 4
Padova 4
Porto Alegre 4
Totale 3.455
Salva come PNG Salva come JPEG
Nome #
Immune Activation in α-1antitrypsin Deficiency Emphysema: Beyond the Protease/Antiprotease Paradigm. 155
Lyosecretome for use in the treatment of autoimmune diseases 121
Lyosecretome for use in the treatment or prevention of skin aging by inhibiting elastase and tyrosinase activity 120
Lyosecretome for use in the treatment of degenerative osteoarticular diseases and/or degenerative intervertebral disc disease. 118
Advances in Identifying Urine/Serum Biomarkers in Alpha-1 Antitrypsin Deficiency for More Personalized Future Treatment Strategies 117
A Pilot Study to Investigate the Balance between Proteases and α1-Antitrypsin in Bronchoalveolar Lavage Fluid of Lung Transplant Recipients. 110
Adipose Mesenchymal Extracellular Vesicles as Alpha-1-Antitrypsin Physiological Delivery Systems for Lung Regeneration 110
A regulatory SNP in the Promoter Region of the RAGE Gene 102
Complement receptor 1 gene polymorphisms are associated with idiopathic pulmonary fibrosis. 101
Expression of receptor for advanced glycation end products in sarcoid granulomas. 101
Lyosecretome for use in the treatment of alpha-1-antitrypsin deficiency associated diseases 100
Inherited alpha1-antitrypsin deficiency: Is the level the key message? 96
Mesenchymal Extracellular Vesicles as Alpha-1-antitrypsin physiological delivery systems for lung regeneration 96
In vitro T-cell immune reactivity against promiscuous frames of hepatitis C virus core protein predicted by computational analysis 94
α₁-Antitrypsin level and pheno/genotypes 93
Identification and characterisation of eight novel SERPINA1 null mutations. 92
Causal and synthetic associations of variants in the SERPINA gene cluster with alpha1-antitrypsin serum levels. 91
Freeze-dried MSC-secretome contains active alpha-1-antitrypsin for treatment of deficiency pulmonary diseases 90
Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications. 86
The role of bronchial epithelial cells in the pathogenesis of COPD in Z-alpha-1 antitrypsin deficiency. 84
Interactions between SERPINA1 PiMZ genotype, occupational exposure and lung function decline. 84
Case-finding for alpha1-antitrypsin deficiency in Kazakh patients with COPD 84
Alpha-1 antitrypsin deficiency: From the lung to the heart? 83
Freeze-dried MSC-secretome for use in the treatment of alpha-1-antitrypsin deficiency pulmonary diseases 82
COPD: no gene left unturned 80
MSC extracellular vesicles for treatment of alpha-1-antitrypsin deficiency pulmonary diseases 80
Identification of a novel alpha1-antitrypsin null variant (Q0Cairo). 79
Bacterial load and inflammatory response in sputum of alpha-1 antitrypsin deficiency patients with COPD 79
Clinical phenotypes of Italian and Spanish patients with α1-antitrypsin deficiency. 77
Protein expression in sputum of smokers and chronic obstructive pulmonary disease patients: a pilot study by CapLC-ESI-Q-TOF. 77
SERPINA1 PiZ and PiS heterozygotes and lung function decline in the SAPALDIA cohort. 74
The European Alpha-1 Research Collaboration (EARCO): a new ERS Clinical Research Collaboration to promote research in alpha-1 antitrypsin deficiency 71
In vitro T-cell immune reactivity against promiscuous frames on hepatitis C virus core proteine predicted by computational analysis 69
Italian registry of patients with alpha-1 antitrypsin deficiency: General data and quality of life evaluation 68
Mesenchymal Stromal Cell Secretome for Post-COVID-19 Pulmonary Fibrosis: A New Therapy to Treat the Long-Term Lung Sequelae? 68
Comparison among populations with severe and intermediate alpha1-antitrypsin deficiency and chronic obstructive pulmonary disease 68
Clinical features in patients with severe Alpha-1 antitrypsin deficiency due to rare genotypes 66
The pathological Trento variant of alpha-1-antitrypsin (E75V) shows nonclassical behaviour during polymerization. 63
An Italian expert consensus on the management of alpha1-antitrypsin deficiency: a comprehensive set of algorithms 61
Kruppel-like zinc finger proteins in end-stage COPD lungs with and without severe alpha1-antitrypsin deficiency. 60
Update on α1-antitrypsin deficiency 60
Practical dietary advices for subjects with alpha-1 antitrypsin deficiency 57
Alpha1-Antitrypsin Inherited Variants in Patients With Bronchiectasis 57
Improving the Laboratory Diagnosis of M-like Variants Related to Alpha1-Antitrypsin Deficiency 57
Mesenchymal stem/stromal cell secretome for lung regeneration: The long way through “pharmaceuticalization” for the best formulation. 55
Clinical manifestations of a new alpha-1 antitrypsin genetic variant: Q0parma 53
Efficacy of augmentation therapy for emphysema associated with α1-antitrypsin deficiency: Enough is enough 52
α1-Antitrypsin deficiency. 50
Real-world clinical applicability of pathogenicity predictors assessed on SERPINA1 mutations in alpha-1-antitrypsin deficiency. 50
Comprehensive Clinical Diagnostic Pipelines Reveal New Variants in Alpha-1 Antitrypsin Deficiency 50
Immune Activation in alpha(1)-Antitrypsin-Deficiency Emphysema Beyond the Protease-Antiprotease Paradigm 49
Molecular diagnosis of alpha1-antitrypsin deficiency: A new method based on Luminex technology 47
Protein expression in sputum of smokers and chronic obstructive pulmonary disease patients: a pilot study by CapLC-ESI-Q-TOF. 47
Recommendations for the measurement of the most important plasma proteins 46
Rare variants in alpha 1 antitrypsin deficiency: a systematic literature review 45
Alternative transcripts of the SERPINA1 gene in alpha-1 antitrypsin deficiency 45
Severe alpha-1 antitrypsin deficiency in composite heterozygotes inheriting a new splicing mutation QOMadrid. 45
COVID-19 infection in severe Alpha 1-antitrypsin deficiency: Looking for a rationale 44
Distribution of the Clinical Manifestations of Alpha 1 Antitrypsin Deficiency in Respiratory Outpatients from an Area of Northern Italy 44
Comparison of different algorithms in laboratory diagnosis of alpha1-antitrypsin deficiency 42
Smart Sensors and Microtechnologies in the Precision Medicine Approach against Lung Cancer 42
Quantification of circulating alpha-1-antitrypsin polymers associated with different SERPINA1 genotypes 42
European Respiratory Society statement: diagnosis and treatment of pulmonary disease in α1-antitrypsin deficiency. 39
The Genes–Stemness–Secretome Interplay in Malignant Pleural Mesothelioma: Molecular Dynamics and Clinical Hints 39
Sanger and Next-Generation Sequencing of AAT 38
Mesenchymal Stromal Cell Secretome for Severe COVID-19 Infections: Premises for the Therapeutic Use 38
Alpha1-antitrypsin deficiency in Greece: Focus on rare variants 37
Place of genotyping and phenotype in addition to the assay of serum α -1 antitrypsin 34
Improving the diagnosis of AATD with aid of serum protein electrophoresis: A prospective, multicentre, validation study 34
How can we improve the detection of Alpha1-antitrypsin deficiency? 34
Clinical manifestations in patients with PI*MMMalton genotypes. A matter still unsolved in alpha-1 antitrypsin deficiency 33
Air Trapping Is Associated with Heterozygosity for Alpha-1 Antitrypsin Mutations in Patients with Asthma 33
SERPINA1 gene variants in individuals from the general population with reduced ?1-antitrypsin concentrations 31
Protocol for the earco registry: A pan-european observational study in patients with α1-antitrypsin deficiency 30
Complement receptor 1 gene polymorphisms in sarcoidosis. 30
Effect of α1 antitrypsin deficiency on lung volume decline in severe asthmatic patients undergoing biologic therapy 29
Long-term effect of α1-antitrypsin augmentation therapy on the decline of fev1 in deficient patients: An analysis of the air database 27
Transplant with MZ genotype liver: what is the clinical pulmonary picture after 30 years? a case report and review of the literature 27
Alpha-1 antitrypsin deficiency is significantly associated with atopy in asthmatic patients 27
Alpha-1 antitrypsin screening in a selected cohort of patients affected by chronic pulmonary diseases in Naples, Italy 26
Exome Sequencing Reveals Immune Genes as Susceptibility Modifiers in Individuals with α1-Antitrypsin Deficiency 26
The importance of n186 in the alpha-1-antitrypsin shutter region is revealed by the novel bologna deficiency variant 25
What is the knowledge on alpha-1 antitrypsin deficiency among Italian pulmonologists? 25
Electrophoretic α1-globulin for screening of α1-antitrypsin deficient variants 22
Diagnosis and treatment of pulmonarydisease in alfa-1-antitrypsin deficiency: A statement of European Respiratory Society 22
New patient-centric approaches to the management of alpha-1 antitrypsin deficiency 20
Research priorities in α1-antitrypsin deficiency: Results of a patients’ and healthcare providers’ international survey from the earco clinical research collaboration 19
PI*ZQ0Attikon genotype discovery in severe alpha-1 antitrypsin deficiency 15
Phenotypic Expression of Respiratory Diseases and Tailored Treatment in Patients with Intermediate Alpha-1 Antitrypsin Deficiency: Evidence from a Retrospective Analysis of a Selected Cohort of Patients 15
Investigating the Link between Alpha-1 Antitrypsin Deficiency and Abdominal Aortic Aneurysms 14
Alpha-1 antitrypsin deficiency-associated liver disease: A review focusing on new assessment tools and therapies 11
The phenotypic state of bi allelic SERPINA1 Q0 variants in alpha-1 antitrypsin deficiency 11
Performance of enhanced liver fibrosis test and indirect serum fibrosis markers for exclusion of advanced liver fibrosis in alpha-1 antitrypsin deficiency 5
Totale 5.445
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.453
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.453
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021160 0 0 0 0 0 0 14 47 13 33 29 24
2021/2022199 6 2 4 5 1 2 5 16 13 4 28 113
2022/2023712 85 49 6 44 82 68 3 30 308 7 20 10
2023/2024395 26 75 16 10 35 98 11 20 2 53 27 22
2024/20251.476 20 71 76 90 30 134 57 80 329 70 185 334
2025/20261.645 235 200 322 348 379 158 3 0 0 0 0 0
Totale 5.445